• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bio-Techne Corp - Common Stock (NQ:TECH)

70.65 -0.25 (-0.35%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bio-Techne Corp - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
News headline image
Bio-Techne (TECH) Q1 2026 Earnings Call Transcript ↗
November 06, 2025
Bio-Techne (TECH) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Earnings Season Echoes: Navigating the Volatility of Corporate Reports
November 05, 2025
The financial markets are once again in the throes of earnings season, a period that consistently proves to be a crucible for individual stock valuations and a significant driver of broader market... 
Via MarketMinute
Topics Artificial Intelligence Economy Supply Chain
News headline image
These S&P500 stocks that are showing activity before the opening bell on Wednesday. ↗
November 05, 2025
The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements. 
Via Chartmill
News headline image
Earnings Scheduled For November 5, 2025 ↗
November 05, 2025
 
Via Benzinga
News headline image
An Overview of Bio-Techne's Earnings ↗
November 04, 2025
 
Via Benzinga
News headline image
Bio-Techne Corp (NASDAQ:TECH) Shares Drop 7.7% on Q1 Earnings and Revenue Miss ↗
November 05, 2025
Bio-Techne (TECH) stock plunges after missing Q1 FY2026 revenue and EPS estimates, triggering a sharp sell-off in pre-market trading. 
Via Chartmill
News headline image
Bio-Techne (NASDAQ:TECH) Misses Q3 Revenue Estimates, Stock Drops
November 05, 2025
Life sciences company Bio-Techne (NASDAQ:TECH) missed Wall Street’s revenue expectations in Q3 CY2025, with sales falling 1% year on year to $286.6 million. Its non-GAAP profit of $0.42 per share was... 
Via StockStory
News headline image
What To Expect From Bio-Techne’s (TECH) Q3 Earnings
November 03, 2025
Life sciences company Bio-Techne (NASDAQ:TECH) will be announcing earnings results this Wednesday before market hours. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
News headline image
Why Bio-Techne (TECH) Stock Is Up Today
October 31, 2025
Shares of life sciences company Bio-Techne (NASDAQ:TECH) jumped 2.8% in the afternoon session after Baird adjusted its price target on the company, signaling a more positive outlook. The investment... 
Via StockStory
Topics Artificial Intelligence Supply Chain World Trade
News headline image
These S&P500 stocks are moving in today's session ↗
October 27, 2025
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Monday. 
Via Chartmill
News headline image
3 S&P 500 Stocks We’re Skeptical Of
October 24, 2025
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some... 
Via StockStory
Topics Stocks
News headline image
What's going on in today's session: S&P500 movers ↗
October 16, 2025
Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session. 
Via Chartmill
News headline image
3 Reasons to Avoid TECH and 1 Stock to Buy Instead
October 16, 2025
While the S&P 500 is up 26.5% since April 2025, Bio-Techne (currently trading at $59.58 per share) has lagged behind, posting a return of 19.2%. This may have investors wondering how to approach the... 
Via StockStory
Topics Stocks Supply Chain
News headline image
3 Cash-Producing Stocks We Find Risky
October 09, 2025
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak... 
Via StockStory
News headline image
5 Analysts Assess Bio-Techne: What You Need To Know ↗
October 07, 2025
 
Via Benzinga
News headline image
Centene, QuidelOrtho, iRhythm, and Bio-Techne Shares Skyrocket, What You Need To Know
October 02, 2025
A number of stocks jumped in the afternoon session after news of a new government prescription drug policy and a landmark deal with Pfizer eased investor concerns over stricter pricing regulations. 
Via StockStory
Topics Government World Trade
News headline image
What's going on in today's session: S&P500 movers ↗
October 02, 2025
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Thursday. 
Via Chartmill
News headline image
3 Low-Volatility Stocks That Concern Us
October 02, 2025
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies. 
Via StockStory
News headline image
Trump-Pfizer Deal Pushes Health Care Stocks To Best Rally In 5 Years ↗
October 01, 2025
Health care stocks rallied after Trump struck a drug pricing deal with Pfizer, offering major discounts and pausing pharma tariffs. 
Via Benzinga
Topics Government
News headline image
Healthcare Sector Navigates Turbulent Waters as Drug Pricing Agreements Reshape Market Landscape
September 30, 2025
September 30, 2025 – The healthcare sector today finds itself at a pivotal juncture, experiencing a complex mix of optimism and apprehension. While a landmark drug-pricing agreement between... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
News headline image
Agilent (A) Soars as White House-Pfizer Drug-Pricing Agreement Signals New Era for Pharma
September 30, 2025
Washington D.C. – September 30, 2025 – Shares of Agilent Technologies (NYSE: A) experienced a significant upward movement today, closing strong amidst breaking news of a landmark drug-pricing agreement... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
News headline image
Pharmaceutical Pricing Shake-Up Casts Long Shadow on Biotech Suppliers, Bruker Navigates Headwinds Amidst Market Volatility
September 30, 2025
As of September 30, 2025, the financial markets are grappling with the implications of a landmark drug-pricing agreement between the White House and pharmaceutical giant Pfizer (NYSE: PFE), a move... 
Via MarketMinute
Topics Economy Government Supply Chain
News headline image
Bruker, Agilent, Revvity, Avantor, and Bio-Techne Shares Are Soaring, What You Need To Know
September 30, 2025
A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry. 
Via StockStory
Topics Government
News headline image
Bio-Techne (TECH) Shares Skyrocket, What You Need To Know
September 30, 2025
Shares of life sciences company Bio-Techne (NASDAQ:TECH) jumped 5.3% in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical... 
Via StockStory
Topics Government
News headline image
What's going on in today's session: S&P500 movers ↗
September 30, 2025
Stay informed about the performance of the S&P500 index one hour before the close of the markets on Tuesday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
News headline image
What's going on in today's session: S&P500 movers ↗
September 24, 2025
Stay informed about the performance of the S&P500 index one hour before the close of the markets on Wednesday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
News headline image
Which S&P500 stocks are gapping on Wednesday? ↗
September 24, 2025
Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Wednesday. Stay informed about the latest market trends. 
Via Chartmill
News headline image
Corporate Investment Rebound: Will Cheaper Borrowing Catalyze Business Expansion and Job Growth?
September 17, 2025
The financial markets are abuzz following the Federal Reserve's recent decision to cut interest rates, a move widely interpreted as an attempt to inject new vigor into the economy. This policy shift... 
Via MarketMinute
Topics Bonds Economy Supply Chain
News headline image
Fed Trims Rates by 0.25%: A New Era of Dovish Policy and Portfolio Rebalancing
September 17, 2025
The Federal Reserve has announced a 0.25% reduction in its benchmark interest rate, marking a significant shift towards a more accommodative monetary policy. This move, while seemingly modest, carries... 
Via MarketMinute
Topics Bonds Credit Cards Economy
News headline image
Research Tools & Consumables Stocks Q2 Highlights: Bio-Techne (NASDAQ:TECH)
September 16, 2025
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the research tools & consumables stocks, including Bio-Techne (NASDAQ:TECH) and its peers. 
Via StockStory
Topics Economy
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap